• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Exposure to Fine Particulate Air Pollution Is Associated with Endothelial Injury and Systemic Inflammation

tetano

Editor, Senior Moderator
[h=1]Exposure to Fine Particulate Air Pollution Is Associated with Endothelial Injury and Systemic Inflammation[/h] C A Pope, Aruni Bhatnagar, James McCracken, Wesley T Abplanalp, Daniel J Conklin and Timothy E O'Toole

http://dx.doi.org/10.1161/CIRCRESAHA.116.309279 Circulation Research. 2016;CIRCRESAHA.116.309279
Originally published October 25, 2016



[h=2]Abstract[/h] Rationale: Epidemiologic evidence indicates that exposures to fine particulate matter air pollution (PM[SUB]2.5[/SUB]) contribute to global burden of disease, primarily as a result of increased risk of cardiovascular morbidity and mortality. However, mechanisms by which PM[SUB]2.5[/SUB] exposure induces cardiovascular injury remain unclear. PM[SUB]2.5[/SUB]-induced endothelial dysfunction and systemic inflammation have been implicated, but direct evidence is lacking.
Objective: To examine whether acute exposure to PM[SUB]2.5[/SUB] is associated with endothelial injury and systemic inflammation.
Methods and Results: Blood was collected from healthy, non-smoking, young adults over three study periods that included episodes of elevated PM[SUB]2.5[/SUB] levels. Microparticles and immune cells in blood were measured by flow cytometry, and plasma cytokine/growth factors were measured using multiplexing laser beads. PM[SUB]2.5[/SUB] exposure was associated with elevated levels of endothelial microparticles (annexin V[SUP]+[/SUP]/CD41-/CD31[SUP]+[/SUP]) including subtypes expressing arterial-, venous-, and lung-specific markers, but not microparticles expressing CD62[SUP]+[/SUP]. These changes were accompanied by suppressed circulating levels of pro-angiogenic growth factors (EGF, sCD40L, PDGF, RANTES, GROα, and VEGF), and an increase in the levels of anti-angiogenic (TNFα, IP-10) and proinflammatory cytokines (MCP-1, MIP-1α/β, IL-6, and IL-1β), and markers of endothelial adhesion (sICAM-1 and sVCAM-1). PM[SUB]2.5[/SUB] exposure also was associated with an inflammatory response characterized by elevated levels of circulating CD14[SUP]+[/SUP], CD16[SUP]+[/SUP], CD4[SUP]+[/SUP], and CD8[SUP]+[/SUP], but not CD19[SUP]+[/SUP] cells.
Conclusions: Episodic PM[SUB]2.5[/SUB] exposures are associated with increased endothelial cell apoptosis, an anti-angiogenic plasma profile, and elevated levels of circulating monocytes, and T, but not B, lymphocytes. These changes could contribute to the pathogenic sequelae of atherogenesis and acute coronary events.

http://circres.ahajournals.org/content/early/2016/10/19/CIRCRESAHA.116.309279
 
Back
Top